Merck Announces Plans for Licensing Atripla Widely in Developing World
...ollaboration between Merck, the license holder for efavirenz outside the US and western Europe, and Gilead, the license holder of tenofovir and emtricitabine. In contrast to Gilead's policy with tenofovir, where the company has granted voluntary licenses in India and South Africa, Atripla commercialisation wil...Merck Cuts Price of Efavirenz for Developing Countries Again
Merck & Co has cut the price of efavirenz 600mg tablets (Stocrin) for developing countries t...and crucially, it will make the branded version of efavirenz cheaper than a generic import in Thailand, where a compulsory license was recently issued to allow i...Cipla launches 3-in-1 AIDS drug in India
...effective treatment. // The three anti-HIV drugs efavirenz 600 mg, tenofovir 300 mg and emtricitabine 200mg comprise the drug Viraday.Viraday, one tablet of which alone effectively treats a HIV infected person, eliminates the need for 3 separate medicines. This drug has some advantages like, it is less burde...Four-Drug AIDS Treatment Regimen Deemed Of No Use
... either the medications zidovudine/lamivudine plus efavirenz (3-drug regimen) or zidovudine/lamivudine/abacavir plus efavirenz (4-drug regimen). Overall, 26 percent of 382 patients receiving the 3-drug regimen and 25 percent ......ed lopinavir/ritonavir. Moreover, a third regimen, efavirenz and lopinavir/ritonavir, performed nearly as well ...in some patients. 'Our findings suggest that the efavirenz plus two-NRTI regimen was the best of the three approaches as initial therapy, even in patients with...